gennova-biopharmaceuticals-limitedgennova-biopharmaceuticals-limited
  • Home
    • Home
    • Contact Us
    • Careers
  • About Us
    • About Us
    • Company Profile
    • Our Values
    • Board of Directors
    • Our Strengths
    • PDL
    • Our Collaborations
  • Media
    • Media
    • News Coverage
    • Gallery
    • Employee Moments
  • Products
    • Products
    • Elaxim®
    • GEMCOVAC®-OM
    • Hamsyl®
    • Hamsyl® Junior
    • PEGEX®
    • TENECTASE®
    • Vintor®
    • Xgrast®
  • Publications
  • Abhyudaya
  • Transforming Healthcare
    • Transforming Healthcare
    • Global Health Initiative
      • Global Health Initiative
      • PHT
Gennova Logo Gennova Logo
  • Home
    • Home
    • Contact Us
    • Careers
  • About Us
    • About Us
    • Company Profile
    • Our Values
    • Board of Directors
    • Our Strengths
    • PDL
    • Our Collaborations
  • Media
    • Media
    • News Coverage
    • Gallery
    • Employee Moments
  • Products
    • Products
    • Elaxim®
    • GEMCOVAC®-OM
    • Hamsyl®
    • Hamsyl® Junior
    • PEGEX®
    • TENECTASE®
    • Vintor®
    • Xgrast®
  • Publications
  • Abhyudaya
  • Transforming Healthcare
    • Transforming Healthcare
    • Global Health Initiative
      • Global Health Initiative
      • PHT

Category : Product Publications

Home Page /  Product Publications
 
Hamsyl®, Product Publications

Experience with Generic Pegylated L-asparaginase in Children with Acute Lymphoblastic Leukemia from a Tertiary Care Oncology Center in South India

  • admin
  • November 4, 2024
South Asian J Cancer, 2023 Apr 10;12(4):371-377. doi: 10.1055/s-0042-1759785 https://pubmed.ncbi.nlm.nih.gov/38130281/
Read More
Share
Hamsyl®, Product Publications

Systematic clinical and pharmacological monitoring of a PEG-asparaginase biogeneric (HAMSYL®) in paediatric patients with newly-diagnosed acute lymphoblastic leukaemia

  • admin
  • November 4, 2024
Pediatr Hematol Oncol. 2023; 8(4):S48. doi: 10.1016/j.phoj.2023.10.122 https://www.sciencedirect.com/science/article/pii/S2468124523001821?via%3Dihub
Read More
Share
Hamsyl®, Product Publications

Randomized, Parallel Group, Open-Label Bioequivalence Trial of Intramuscular Pegaspargase in Patients With Relapsed Acute Lymphoblastic Leukemia

  • admin
  • July 20, 2020
JCO Glob Oncol. 2020 Jul;6:1009-1016. doi: 10.1200/GO.20.00113. https://pubmed.ncbi.nlm.nih.gov/32628582/
Read More
Share
PEGEX®, Product Publications

Establishment of the first international standard for PEGylated granulocyte colony stimulating factor (PEG-G-CSF): Report of an international collaborative study

  • admin
  • April 9, 2020
J Immunol Methods. 2015 Jan;416:17-28. doi: 10.1016/j.jim.2014.10.005. https://www.ncbi.nlm.nih.gov/pubmed/25450254
Read More
Share
Emgrast®, Product Publications

Assessing analytical comparability of biosimilars: GCSF as a case study

  • admin
  • April 9, 2020
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Oct 1;1032:165-171. doi: 10.1016/j.jchromb.2016.05.027. https://www.ncbi.nlm.nih.gov/pubmed/27289250
Read More
Share
Hamsyl®, Product Publications

Retrospective post-marketing study on the use of bio-similar pegasparagase among acute lymphoblastic leukemia patients in India

  • admin
  • April 9, 2020
Pediatric Hematology Oncology Journal, Volume 3, Issue 1, March 2018, Pages 9-12 https://www.sciencedirect.com/science/article/pii/S2468124517301031
Read More
Share
Hamsyl®, Product Publications

Experience with generic pegylated L-asparaginase in children with acute lymphoblastic leukemia and monitoring of serum asparaginase activity.

  • admin
  • April 9, 2020
Pediatr Hematol Oncol. 2018 Aug – Sep;35(5-6):331-340. doi: 10.1080/08880018.2018.1538277 https://www.ncbi.nlm.nih.gov/pubmed/30488741
Read More
Share
Product Publications, Tenectase®

Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.

  • admin
  • April 9, 2020
Am J Cardiovasc Drugs. 2018 Oct;18(5):387-395. doi: 10.1007/s40256-018-0284-1. https://www.ncbi.nlm.nih.gov/pubmed/29948822
Read More
Share
Elaxim™, Product Publications

Efficacy and safety of tenecteplase in diabetic and non-diabetic patients of STEMI – Indian registry data

  • admin
  • April 9, 2020
J Assoc Physicians India. 2010 Apr;58:229-30. https://www.ncbi.nlm.nih.gov/pubmed/21046876
Read More
Share
Elaxim™, Product Publications

Tenecteplase in the treatment of acute pulmonary thrombo-embolism.

  • admin
  • April 9, 2020
J Thromb Thrombolysis. 2011 May;31(4):445-8. doi: 10.1007/s11239-010-0524-y. https://www.ncbi.nlm.nih.gov/pubmed/20972606
Read More
Share
1 2 next page
Gennova Logo

About Gennova

Board of Directors
Research Collaborations
Corporate Governance
Internships
Careers
Press Kit
Contact Us

Products

Elaxim®
GEMCOVAC®-OM
Hamsyl®
Hamsyl® Junior

PEGEX®
TENECTASE®
Vintor®
Xgrast®

©2006-2025 Gennova Biopharmaceuticals Limited. All rights reserved.